Bortezomib, Bendamustine and Dexamethasone vs Thalidomide, Bendamustine and Dexamethasone in Myeloma patients presenting with renal failure (OPTIMAL): a randomised, multi-centre phase II trial.
Ontology highlight
SUBMITTER: Ramasamy K
PROVIDER: S-EPMC9708638 | biostudies-literature | 2022 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA